UNIVERSITY TRUSTEES AS CHANNELS BETWEEN ACADEME AND INDUSTRY: TOWARD AN UNDERSTANDING OF THE EXECUTIVE SCIENCE NETWORK.
作者信息
Mathies Charles, Slaughter Sheila
机构信息
Senior Expert - Strategic Planning & Development, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.
出版信息
Res Policy. 2013;42(6-7):1286-1300. doi: 10.1016/j.respol.2013.03.003.
Abstract
摘要
相似文献
1
UNIVERSITY TRUSTEES AS CHANNELS BETWEEN ACADEME AND INDUSTRY: TOWARD AN UNDERSTANDING OF THE EXECUTIVE SCIENCE NETWORK.大学受托人作为学术界与产业界之间的桥梁：迈向对行政科学网络的理解
Res Policy. 2013;42(6-7):1286-1300. doi: 10.1016/j.respol.2013.03.003.
2
Governance of hospitals in Canada: a survey of business leaders who serve as hospital trustees.加拿大医院治理：对担任医院受托人的企业领导者的一项调查。
Healthc Manage Forum. 1993 Summer;6(2):5-12. doi: 10.1016/S0840-4704(10)61084-8.
3
Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study.美国上市医疗保健公司董事会中学术领袖、教授和受托人任职情况及薪酬：横断面研究
BMJ. 2015 Sep 29;351:h4826. doi: 10.1136/bmj.h4826.
4
How trustees' attitudes affect executive compensation decisions.受托人态度如何影响高管薪酬决策。
Trustee. 1986 Oct;39(10):16-8.
5
Trustee Week: education for trustees, by trustees.受托人周：由受托人开展的受托人教育活动。
Trustee. 1980 Jun;33(6):25-8.
6
Promoting the Medical University's Governance: Content Analysis of Decisions Made by the Medical University's Governing Bodies.促进医科大学治理：对医科大学管理机构所作决策的内容分析
Arch Iran Med. 2016 Dec;19(12):832-837.
7
Academe and industry debate partnership.
Science. 1983 Jan 14;219(4581):150-1. doi: 10.1126/science.11643998.
8
Health system organizational reform in governing Iranian public hospitals: A content analysis to comprehend the barriers in Board of Trustees' hospitals.伊朗公立医院治理中的卫生系统组织改革：一项旨在理解公立医院董事会医院中障碍的内容分析。
Int J Health Plann Manage. 2018 Apr;33(2):e612-e620. doi: 10.1002/hpm.2500. Epub 2018 Mar 24.
9
Demystifying the boardroom. Tips for timid trustees.揭开董事会的神秘面纱。给胆小的受托人一些建议。
Health Prog. 1989 Nov;70(9):32-6.
10
Leadership by example: saying no to health industry board membership.以身作则：拒绝担任健康产业董事会成员。
BMJ. 2015 Sep 29;351:h5065. doi: 10.1136/bmj.h5065.
本文引用的文献
1
What are the respective roles of the public and private sectors in pharmaceutical innovation?在药品创新方面，公共部门和私营部门各自扮演什么角色？
Health Aff (Millwood). 2011 Feb;30(2):332-9. doi: 10.1377/hlthaff.2009.0917.
2
U.S. research universities' institutional conflict of interest policies.美国研究型大学的机构利益冲突政策。
J Empir Res Hum Res Ethics. 2009 Sep;4(3):3-20. doi: 10.1525/jer.2009.4.3.3.
3
Investigating Perceived Institutional Review Board Quality and Function Using the IRB Researcher Assessment Tool.使用机构审查委员会（IRB）研究者评估工具调查感知到的机构审查委员会质量和功能
J Empir Res Hum Res Ethics. 2008 Mar;3(1):25-34. doi: 10.1525/jer.2008.3.1.25.
4
Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry.机构审查委员会成员及主席对研究者与行业关系的看法。
J Empir Res Hum Res Ethics. 2008 Mar;3(1):3-13. doi: 10.1525/jer.2008.3.1.3.
5
IRB Chairs' Perspectives on Genomics Research Involving Stored Biological Materials: Ethical Concerns and Proposed Solutions.机构审查委员会主席对涉及储存生物材料的基因组学研究的看法：伦理问题与建议解决方案
J Empir Res Hum Res Ethics. 2008 Dec;3(4):99-111. doi: 10.1525/jer.2008.3.4.99.
6
International analysis of institutional review boards registered with the u.s. Office for human research protections.对在美国人类研究保护办公室注册的机构审查委员会的国际分析。
J Empir Res Hum Res Ethics. 2008 Dec;3(4):49-56. doi: 10.1525/jer.2008.3.4.49.
7
Institutional academic industry relationships.机构的学术与行业关系。
JAMA. 2007 Oct 17;298(15):1779-86. doi: 10.1001/jama.298.15.1779.
8
Financial relationships between institutional review board members and industry.机构审查委员会成员与行业之间的财务关系。
N Engl J Med. 2006 Nov 30;355(22):2321-9. doi: 10.1056/NEJMsa061457.
9
Implementation of financial disclosure policies to manage conflicts of interest.实施财务披露政策以管理利益冲突。
Health Aff (Millwood). 2004 Mar-Apr;23(2):206-14. doi: 10.1377/hlthaff.23.2.206.
10
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.生物医学研究中经济利益冲突的范围与影响：一项系统综述
JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.
Zotero 插件